Title:
ＨＩＶ ｇｐ１２０を標的化する抗体および使用方法
Document Type and Number:
Japanese Patent JP7455156
Kind Code:
B2
Abstract:
Antibodies that bind to HIV gp120 and neutralize HIV are disclosed. Also disclosed are methods of using such antibodies alone or in combination with other therapeutic agents to treat or prevent HIV infection.
Inventors:
Mini rose Krishnan
Brian A. Car
Magderin S. Hang
Manu Kanwar
Craig S. Pace
Doug Radar
Matthew Robert Shenauer
Loredana Serafini
Heather Terisa Stevenson
Nathan Dee. Thomsen
Helen You
Shuejan
Brian A. Car
Magderin S. Hang
Manu Kanwar
Craig S. Pace
Doug Radar
Matthew Robert Shenauer
Loredana Serafini
Heather Terisa Stevenson
Nathan Dee. Thomsen
Helen You
Shuejan
Application Number:
JP2022073226A
Publication Date:
March 25, 2024
Filing Date:
April 27, 2022
Export Citation:
Assignee:
Gilead Sciences, Inc.
International Classes:
C12N15/13; A61K39/395; A61P31/18; A61P43/00; C07K16/10; C12N1/19; C12N5/0783; C12N5/10
Domestic Patent References:
| JP5505611A | ||||
| JP2009532477A |
Attorney, Agent or Firm:
Shusaku Yamamoto
Natsuki Morishita
Natsuki Morishita
Previous Patent: Polyvinyl alcohol resin and its manufacturing method
Next Patent: liquid naloxone spray
Next Patent: liquid naloxone spray